🇺🇸 FDA
Pipeline program

10 mg PRAX-114, 20 mg PRAX-114, and Placebo

PRAX-114-231

Phase 2 small_molecule terminated

Quick answer

10 mg PRAX-114, 20 mg PRAX-114, and Placebo for Essential Tremor is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Essential Tremor
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials